Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 57,400 shares, a decline of 44.8% from the March 31st total of 104,000 shares. Based on an average daily trading volume, of 254,100 shares, the short-interest ratio is currently 0.2 days. Approximately 1.8% of the company’s shares are sold short.
Wall Street Analyst Weigh In
Separately, Benchmark cut their price target on Tenon Medical from $5.00 to $3.00 and set a “speculative buy” rating on the stock in a report on Monday, April 15th.
Read Our Latest Report on TNON
Tenon Medical Stock Performance
Tenon Medical (NASDAQ:TNON – Get Free Report) last posted its quarterly earnings results on Tuesday, March 12th. The company reported ($0.68) EPS for the quarter. The company had revenue of $0.81 million during the quarter. Tenon Medical had a negative return on equity of 934.11% and a negative net margin of 532.14%.
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints.
Further Reading
- Five stocks we like better than Tenon Medical
- How to Capture the Benefits of Dividend Increases
- MarketBeat Week in Review – 4/22 – 4/26
- How to Find Undervalued Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- How is Compound Interest Calculated?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.